Aug 12, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma | Faculty Presentation 2: Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates for MM — Jesús G Berdeja, MD

CME information and select...

Aug 12, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma | Faculty Presentation 1: Current and Emerging Therapeutic Approaches for Multiple Myeloma (MM) — Thomas Martin, MD

CME information and select...

Aug 12, 2024

Featuring perspectives from Dr Jesús G Berdeja and Dr Thomas Martin, including the following topics:

• Introduction: Real-World Regulatory Issues in Multiple Myeloma (MM) (0:00)
• Newly Diagnosed MM (14:30)
• Novel Agents for Relapsed/Refractory MM (24:58)
• Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies...

Jul 12, 2024

Featuring perspectives from Dr Joshua Brody, Dr Ian W Flinn and Dr Tycel Phillips, including the following topics:

• Introduction: CD3 Bispecific Antibodies in the Community Oncology Setting (0:00)
• Integration of Bispecific Antibody Therapy into the Management of Diffuse Large B-Cell Lymphoma — Dr Phillips (18:13)

Jul 9, 2024

Featuring perspectives from Dr Rafael Fonseca, Dr María-Victoria Mateos and Dr Elizabeth O’Donnell, moderated by Dr O’Donnell, including the following topics:

• Introduction (0:00)
• Treatment Approaches for Newly Diagnosed Multiple Myeloma (MM) — Dr Fonseca (2:05)
• Role of Chimeric Antigen Receptor T-Cell Therapy...